By Trent Stockton
Johns Hopkins Medicine

To make sure that urologist Patrick Walsh's winning approach to the prevention, treatment and ultimate cure of prostate cancer will continue, a group of his former patients raised $25 million to provide funds to support the research of outstanding scientists from throughout The Johns Hopkins University. The goal of the fund is to attract the best and brightest scientists to join in the fight against prostate cancer.

The Patrick C. Walsh Prostate Cancer Research Fund is named in honor of Walsh, who for three decades served as urologist in chief and director of the Department of Urology and the Brady Urological Institute at Johns Hopkins. Walsh is stepping down from his administrative duties as director to devote more time to patient care, surgery and research.

"Under Dr. Walsh's leadership, the Brady Urological Institute led the world in the fight against prostate cancer," said Edward D. Miller, dean/CEO of Johns Hopkins Medicine. "We hope the Walsh Fund will help continue the legacy of discovery he has created."

The Walsh Fund is off to a powerful start, with $25 million raised in just two years by the Brady Advisory Council to provide support for research, equipment and laboratories. The first grants, ranging from $50,000 to $100,000, will be awarded in spring 2005. All applications are reviewed by a scientific advisory board made up of Johns Hopkins faculty and patients who are knowledgeable about the management and treatment of prostate cancer. The goal is to ensure that multidisciplinary efforts, incorporating urologists, basic scientists, medical and radiation oncologists, pathologists and others, are harnessed in the fight against the most common cancer in men.

GO TO NOVEMBER 29, 2004 TABLE OF CONTENTS.
GO TO THE GAZETTE FRONT PAGE.